Company Quick10K Filing
Quick10K
Aixin Life
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-11-30 Quarter: 2017-11-30
10-Q 2017-08-31 Quarter: 2017-08-31
10-K 2017-05-31 Annual: 2017-05-31
10-Q 2017-02-28 Quarter: 2017-02-28
10-Q 2016-11-30 Quarter: 2016-11-30
10-Q 2016-08-31 Quarter: 2016-08-31
10-K 2016-05-31 Annual: 2016-05-31
10-Q 2016-02-29 Quarter: 2016-02-29
10-Q 2015-11-30 Quarter: 2015-11-30
10-Q 2015-08-31 Quarter: 2015-08-31
10-K 2015-05-31 Annual: 2015-05-31
10-Q 2015-02-28 Quarter: 2015-02-28
10-Q 2014-11-30 Quarter: 2014-11-30
10-Q 2014-08-31 Quarter: 2014-08-31
10-K 2014-05-31 Annual: 2014-05-31
10-Q 2014-02-28 Quarter: 2014-02-28
10-Q 2013-11-30 Quarter: 2013-11-30
8-K 2019-10-09 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-08-20 Amendment
8-K 2019-08-07 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-07-13 Accountant
8-K 2019-04-29 Accountant, Exhibits
SWAV ShockWave Medical 1,180
HOFD HomeFed 884
ARII American Railcar Industries 793
CRBO Carbon Energy 74
FMFG Farmers & Merchants Bancshares 52
GBLX GB Sciences 24
SYEV Seychelle Environmental Technologies 8
DQWS DSwiss 0
SQTX Solar Quartz Technologies 0
ACF General Motors Financial Company 0
AIXN 2019-06-30
Part I - Financial Information
Item 1. Financial Statements
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
Item 4. Controls and Procedures.
Part II - Other Information
Item 1. Legal Proceedings
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 5. Other Information
Item 6. Exhibits
EX-31.1 ex31-1.htm
EX-31.2 ex31-2.htm
EX-32.1 ex32-1.htm
EX-32.2 ex32-2.htm

Aixin Life Earnings 2019-06-30

AIXN 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

 

FORM 10-Q

 

(Mark one)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2019

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 0-17284

 

AIXIN LIFE INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Colorado   84-1085935

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

(Address of principal executive offices)

 

86-313-6732526

(Issuer’s telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [  ] No [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer [  ]   Accelerated filer [  ]
Non-accelerated filer [  ]   Smaller reporting company [X]
      Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date: As of September 19, 2019, there were outstanding 297,838,699 shares of the registrant’s common stock.

 

 

 

   
 

 

AIXIN LIFE INTERNATIONAL, INC.

FORM 10-Q

JUNE 30, 2019

INDEX

 

  Page
   
Special Note Regarding Forward Looking Statements 3
     
Part I – Financial Information 4
     
Item 1. Condensed Financial Statements 4
     
  Condensed Balance Sheets 4
     
  Condensed Statements of Operations 5
     
  Condensed Statements of Cash Flows 7
     
  Notes to Condensed Financial Statements 8
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 4. Controls and Procedures 26
     
Part II – Other Information 27
     
Item 1. Legal Proceedings 27
     
Item 1A. Risk Factors 27
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27
     
Item 3. Defaults Upon Senior Securities 27
     
Item 5. Other Information 27
     
Item 6. Exhibits 27
     
  Signatures 28

 

 2 
 

 

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

 

This report contains forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on forward-looking statements. Forward-looking statements include, among other things, statements relating to:

 

  our goals and strategies;
     
  our future business development, financial condition and results of operations;
     
  our expectations regarding demand for, and market acceptance of, our products;
     
  our expectations regarding keeping and strengthening our relationships with merchants, manufacturers and end-users; and
     
  general economic and business conditions in the regions where we provide our services.

 

Also, forward-looking statements represent our estimates and assumptions only as of the date of this report. You should read this report and the documents that we reference and filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

 

Use of Certain Defined Terms

 

Except where the context otherwise requires and for the purposes of this report only:

 

the “Company,” “we,” “us,” and “our” refer, prior to December 12, 2017, the date of the reverse acquisition resulting from the share exchange transaction described in this report, to the registrant, Mercari Communications Group, Ltd., a shell company, and thereafter, to the business of (i) AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”) recently organized for the sole purpose of acquiring all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), formed for the sole purpose of acquiring all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells innovative, premium-quality nutritional products in China. Effective February 1, 2019, pursuant to Articles of Amendment to our Articles of Incorporation filed with the Secretary of State of Colorado, we changed our name to AiXin Life International., Inc. (“AiXin”).

 

“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;

 

“Hong Kong” refers to the Hong Kong Special Administrative Region of the People’s Republic of China;

 

“PRC,” “China,” and “Chinese,” refer to the People’s Republic of China (excluding Hong Kong and Taiwan);

 

“Renminbi” and “RMB” refer to the legal currency of China;

 

“Securities Act” refers to the Securities Act of 1933, as amended; and

 

“US dollars,” “dollars” and “$” refer to the legal currency of the United States.

 

 3 
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

 

   June 30, 2019   December 31, 2018 
   (Unaudited)     
ASSETS          
           
CURRENT ASSETS          
Cash  $3,465   $11,264 
Accounts receivable, net   48,078    36,209 
Other receivables and prepaid expenses   45,063    34,785 
Advances to suppliers   681,040    1,591 
Deferred commission   324,045    338,509 
Deferred travel cost   210,664    220,200 
Inventory   6,268    13,396 
Advances to shareholder   118,218    - 
           
Total current assets   1,436,841    655,954 
           
NONCURRENT ASSETS          
Property and equipment, net   73,706    1,464,415 
Right of use asset   176,029    - 
           
Total non-current assets   249,735    1,464,415 
           
TOTAL ASSETS  $1,686,576   $2,120,369 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Accounts payable  $37,170   $39,927 
Unearned revenue   2,107,501    2,187,267 
Taxes payable   1,218,387    1,222,486 
Accrued liabilities and other payables   776,530    695,375 
Lease liability - current   98,803    - 
Advance from shareholder   -    1,166,198 
           
Total current liabilities   4,238,391    5,311,253 
           
LONG-TERM LIABILITIES:          
Lease liability - non current   77,226    - 
           
TOTAL LIABILITIES   4,315,617    5,311,253 
           
CONTINGENCIES (NOTE 15)          
           
STOCKHOLDERS’ DEFICIT          
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding   -    - 
Common stock, par value $0.00001 per share, 950,000,000 shares authorized; 287,838,699 shares issued and outstanding   2,879    2,879 
Paid in capital   5,644,504    4,395,379 
Statutory reserve   11,721    11,721 
Accumulated deficit   (8,412,041)   (7,736,440)
Accumulated other comprehensive income   123,896    135,577 
           
TOTAL STOCKHOLDERS’ DEFICIT   (2,629,041)   (3,190,884)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $1,686,576   $2,120,369 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 4 
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2019   2018   2019   2018 
                 
Net sales  $10,787   $40,613   $101,266   $145,161 
Cost of Revenue   4,234    24,216    21,430    64,574 
                     
Gross profit   6,553    16,397    79,836    80,587 
                     
Operating expenses                    
Selling   112,734    126,262    236,370    255,056 
General and administrative   255,744    245,384    468,956    593,336 
Provision for bad debts   457    3,927    14,967    8,914 
Asset impairment loss   1,063    -    1,063    - 
                     
Total operating expenses   369,998    375,573    721,356    857,306 
                     
Loss from operations   (363,445)   (359,176)   (641,520)   (776,719)
                     
Non-operating income (expenses)                    
Financial expense   (481)   (220)   (855)   (470)
Loss from sale of building   -    -    (33,166)   - 
Other income   -    107    295    123 
Other expense   (325)   (231)   (355)   (403)
                     
Total non-operating income (expenses), net   (806)   (344)   (34,081)   (750)
                     
Loss before income tax   (364,251)   (359,520)   (675,601)   (777,469)
                     
Provision for income taxes   -    -    -    - 
                     
Net loss   (364,251)   (359,520)   (675,601)   (777,469)
                     
Other comprehensive items                    
Foreign currency translation gain (loss)   68,702    179,855    (11,681)   76,611 
                     
Comprehensive loss  $(295,549)  $(179,665)  $(687,282)  $(700,858)
                     
Loss per share - Basic and diluted  $(0.001)  $(0.001)  $(0.002)  $(0.002)
                     
Weighted average shares outstanding   287,838,699    287,838,699    287,838,699    290,170,696 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 5 
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

(Unaudited)

 

                       Accumulated     
                       Other   Total 
   Common Stock   Paid-in   Statutory   (Accumulated)   Comprehensive   Stockholders’ 
   Shares   Amount   Capital   Reserve   Deficit)   Income (Loss)   Deficit 
Balance, December 31, 2017   317,988,089   $3,180   $3,371,857   $11,721   $(6,386,718)  $(70,154)  $(3,070,114)
Cancellation of stock issued for services   (30,149,390)   (301)   301    -    -    -    - 
Net loss   -    -    -    -    (417,949)   -    (417,949)
Foreign currency translation loss   -    -    -    -    -    (103,244)   (103,244)
Balance, March 31, 2018   287,838,699    2,879    3,372,158    11,721    (6,804,667)   (173,398)   (3,591,307)
Capital contribution by principal shareholder             142,912                   142,912 
Net loss   -    -    -    -    (359,520)   -    (359,520)
Foreign currency translation gain   -    -    -    -    -    179,855    179,855 
Balance, June 30, 2018   287,838,699   $2,879   $3,515,070   $11,721   $(7,164,187)  $6,457   $(3,628,060)
                                    
Balance, December 31, 2018   287,848,699   $2,879   $4,395,379   $11,721   $(7,736,440)  $135,577   $(3,190,884)
Capital contribution by principal shareholder   -    -    313,966    -    -    -    313,966 
Net loss   -    -    -    -    (311,350)   -    (311,350)
Foreign currency translation loss   -    -    -    -    -    (80,384)   (80,384)
Balance, March 31, 2019 (Restated)   287,848,699   2,879   4,709,345   11,721   (8,047,790)  55,194   (3,268,651)
Capital contribution by principal shareholder   -    -    935,159    -    -    -    935,159 
Net loss   -    -    -    -    (364,251)   -    (364,251)
Foreign currency translation gain   -    -    -    -    -    68,702    68,702 
Balance, June 30, 2019   287,848,699   $2,879   $5,644,504   $11,721   $(8,412,041)  $123,896   $(2,629,041)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 6 
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Six Months Ended June 30, 
   2019   2018 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(675,601)  $(777,469)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   80,295    86,000 
Provision for bad debts   14,967    8,914 
Impairment of inventory   -    (15,356)
Loss from sale of building   33,166    - 
Changes in net assets and liabilities:          
Accounts receivable   (26,833)   8,335 
Other receivables and prepaid expenses   (10,264)   (5,407)
Advances to suppliers   (687,533)   1,276 
Deferred commission   15,973    18,092 
Deferred travel cost   10,519    15,867 
Inventory   7,267    48,403 
Accounts payable   (2,947)   17,097 
Unearned revenue   (89,354)   (67,256)
Taxes payable   (8,976)   14,024 
Accrued liabilities and other payables   79,418    196,650 
           
Net cash used in operating activities   (1,259,903)   (450,830)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   -    (1,405)
           
Net cash used in investing activities   -    (1,405)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Lease liability   (8,890)   - 
Capital contribution   1,249,125    142,912 
Change in advance from shareholder   5,146    271,428 
           
Net cash provided by financing activities   1,245,381    414,340 
           
EFFECT OF EXCHANGE RATE CHANGE ON CASH   6,723    3,857 
           
NET DECREASE IN CASH   (7,799)   (34,038)
           
CASH BEGINNING OF PERIOD   11,264    37,630 
           
CASH END OF PERIOD  $3,465   $3,592 
           
Supplemental Cash flow data:          
Income tax paid  $-   $- 
Interest paid  $-   $- 
           
Non-cash investing and financing activities:          
Proceeds from sale of building offset against shareholder loans  $1,326,260   $- 
Right of use asset and related liability  $207,049   $- 
Lease liability paid by shareholder  $17,780   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 7 
 

 

AIXIN LIFE INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019 AND 2018

(Unaudited)

 

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aixin Life International, Inc. (the “Company” or “Aixin” or “we”) was incorporated under the laws of the State of Colorado on December 30, 1987 under the name Mercari Communications Group, Ltd (“Mercari”). From 1988 until 1990, Mercari provided educational products, counseling, seminar programs, and publications such as newsletters to adults aged 30 to 50. Mercari registered its common stock with the Securities and Exchange Commission (the “SEC”) under the Exchange Act in 1988. Mercari’s business failed in 1990. Mercari conducted no operating activities from June 1, 1990 to August 31, 2001 and was dormant.

 

During 2001, Mercari was reactivated. From November 30, 2001 to March 1, 2004, Mercari was in the development stage.

 

On November 9, 2009, Mercari entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Algodon Wines & Luxury Development Group, Inc. or “Algodon” (formerly Diversified Private Equity Corporation or “DPEC”), a then privately-held Delaware corporation, Kanouff, LLC (“KLLC”) and Underwood Family Partners, Ltd. (the “Partnership”), of which KLLC and the Partnership were the majority shareholders of the Company (the “Stock Purchase”). In connection with the Stock Purchase, Algodon purchased and the Company sold, 43,822,001 shares of common stock for $43,822, or $0.001 per share. In addition, Algodon purchased 200 shares of common stock from KLLC and 200 shares of common stock from the Partnership for $180,000 payable to each selling shareholder. Immediately following the closing of the transactions contemplated by the Stock Purchase Agreement, Algodon owned 43,822,401 shares of the Company’s common stock, or 96.5% of our outstanding shares.

 

During each year since Mercari was reactivated until 2017, the Company had no revenue and had losses approximately equal to the expenditures required to reactivate and comply with filing and reporting obligations. Expenditures were paid by Mercari from capital contributions and loans made by Mercari’s principal stockholders and entities controlled by Mercari’s directors.

 

On January 20, 2017, Algodon sold 43,822,401 shares of the Company’s common stock, 96.5% of the Company’s outstanding shares, to China Concentric, for $260,000, and assigned its right to the repayment of $150,087 of non-interest bearing advances to the Company for working capital as the Company’s controlling stockholder, pursuant to a Stock Purchase Agreement dated December 20, 2016, as amended. Prior to entering into the Stock Purchase Agreement with Algodon, neither China Concentric nor any of its affiliates had any relationship to the Company, Algodon or any of their respective affiliates.

 

On February 2, 2017, Mr. Quanzhong Lin purchased 29,521,410 shares of the Company’s common stock, 65.0% of its outstanding shares from China Concentric for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of our company.

 

On December 12, 2017, the Company issued 227,352,604 shares of common stock to Mr. Lin, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for his shares of AiXin BVI, pursuant to a Share Exchange Agreement. Mr. Lin now owns 256,874,014 shares of the Company’s common stock, 89.2% of our outstanding shares.

 

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells premium-quality nutritional products in China.

 

 8 
 

 

AiXin BVI was incorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXin Zhonghong was established in the People’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXin Zhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

 

For accounting purposes, the acquisition was accounted for as a reverse acquisition and treated as a recapitalization of Mercari effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements (“CFS”) of AiXin Zhonghong are now the historical CFS of the Company. The assets and liabilities of AiXin Zhonghong were brought forward at their book value and no goodwill was recognized.

 

Effective February 1, 2018, pursuant to Articles of Amendment to the Company’s Articles of Incorporation filed with the Secretary of State of Colorado, the Company changed its name to AiXin Life International., Inc.

 

The Company, through its indirectly owned AiXin Zhonghong subsidiary, mainly develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. During 2018, the Company’s revenue was primarily generated from sales of products, which include cell food, goat milk power, clear lung Kangbao, light tea, bear gall powders, and other nutritional supplements. During 2019, the Company’s revenue was primarily generated from sales of goat milk power. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying Consolidated Financial Statements (CFS) are prepared in conformity with United States Generally Accepted Accounting Principles (“US GAAP”). The functional currency of Aixin is Chinese Renminbi (‘‘RMB’’). The accompanying CFS are translated from RMB and presented in U.S. dollars (“USD”).

 

The CFS includes the accounts of the Company and its current wholly owned subsidiaries, AiXin HK and AiXin Zhonghong. Intercompany transactions and accounts were eliminated in consolidation.

 

Unaudited Interim Financial Information

 

These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

 

The balance sheets and certain comparative information as of December 31, 2018 are derived from the audited financial statements and related notes for the year ended December 31, 2018 (“2018 Annual Financial Statements”), included in the Company’s 2018 Annual Report on Form 10-K. These unaudited interim financial statements should be read in conjunction with the 2018 Annual Financial Statements.

 

Going Concern

 

The Company incurred net losses of $675,601 and $777,469 for the six months ended June 30, 2019 and 2018, respectively. The Company also had a stockholders’ deficit of approximately $2.6 million as of June 30, 2019. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company plans to increase its income by improving communications with suppliers to ensure sufficient and quality products supply, building a competitive and efficient sales force, providing attractive sales incentive program, increasing marketing and promotion activities, and minimize operating costs. Subsequent to the close of the second quarter, the Company sold 10,000,000 shares of its common stock for gross proceeds of $1,000,000 in a private offering. The Company did not pay any commissions in connection with the sale of the shares. If necessary, the Company will seek to raise additional capital through sales of its equity securities to solve its working capital needs. As of June 30, 2019, the Company received RMB 15.6 million (approximately $2.2 million) from Quanzhong Lin. The CFS do not include any adjustments that might result from the outcome of this uncertainty.

 

Use of Estimates

 

In preparing CFS in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the CFS, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

 9 
 

 

Cash and Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of June 30, 2019 and December 31, 2018, the bad debt allowance was $93,049 and $77,955, respectively.

 

Inventory

 

Inventory mainly consists of health supplement products. Inventory is valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down their inventories to market value, if lower. The Company recorded inventory impairment of $1,063 and $0 for the six months ended June 30, 2019 and 2018, respectively.

 

In July 2015, the FASB issued Accounting Standards Update (“ASU”) 2015-11, “Inventory (Topic 330) - Simplifying the Measurement of Inventory,” which requires that inventory within the scope of the ASU be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Building 20 years
Office furniture 5 years
Electronic Equipment 3 years
Vehicles 5 years

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value (“FV”). FV is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of June 30, 2019 and December 31, 2018, there were no significant impairments of its long-lived assets.

 

 10 
 

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the CFS in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At June 30, 2019 and December 31, 2018, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As sales are and have been primarily from platform fees and related services, and the Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on our accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from sale of goods under Topic 606 in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with our customers that we believe is legally enforceable;

 

  identification of performance obligation in the respective contract;

 

  determination of the transaction price for each performance obligation in the respective contract;

 

  allocation the transaction price to each performance obligation; and

 

  recognition of revenue only when the Company satisfies each performance obligation.

 

 11 
 

 

These five elements, as applied to each of the Company’s revenue categories, is summarized below:

 

 

Revenue from sale of goods is recognized when goods are shipped to the customer and no other obligation exits. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As alternatives for the product return option, the customers have options of asking an exchange of the products with same value.

     
  As part of the Company’s sales incentive program, the Company occasionally provides free travel to its customers whose prepayment to purchase the Company’s products reaches to certain amount. There are different travel incentives offered to the customers based on amount received from each customer. The Company records the to-be-provided free travel cost when cash is collected from customers as a debit deferred travel cost with corresponding credit to accrued travel cost. Once the customer utilizes the travel incentive, the cost of travel is recorded as a reduction of sales.

 

Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price prior to May 1, 2018, 16% since May 1, 2018 and 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Cost of Revenue

 

Cost of revenue (“COR”) consists primarily of cost of purchasing inventory. Write-down of inventory to lower of cost or market is also recorded in COR.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on their cash in these bank accounts.

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

 

Fair Value (“FV”) of Financial Instruments

 

Certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, carrying amounts approximate their FV due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the FV of financial instruments held by the Company. The carrying amounts reported in the balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

 12 
 

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the FV measurement.

 

As of June 30, 2019 and December 31, 2018, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at FV.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the first six months of 2019 and 2018 consisted of net loss and foreign currency translation adjustments.

 

Earnings per Share

 

Basic loss per share is computed on the basis of the weighted average number of common stock outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of June 30, 2019 and 2018 and for the periods then ended, the Company did not have any potentially dilutive instruments.

 

Stock-Based Compensation

 

The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

 13 
 

 

During the year ended December 31, 2017, the Company’s board of directors (“BOD”) authorized the issuance of 45,224,085 shares of common stock to three individuals for services rendered the Company. The stock-based compensation was valued at $3,617,927 based on the Company’s stock price at the date of agreement and was vested immediately for services already rendered. On January 15, 2018, the Company’s BOD determined it was not in the Company’s best interests to issue any shares to two of the three individuals because BOD believes the two individuals did not perform the services as expected.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

Management determined the Company’s operations constitute a single reportable segment in accordance with ASC 280. The Company operates exclusively in one business and industry segment: sale of health supplement products.

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early application is permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its CFS.

 

 14 
 

 

3. ADVANCES TO SUPPLIERS

 

Advances to suppliers include a prepayment of $680,098 to one supplier for donkey hide gelatin powder which is expected to be delivered in October 2019.

 

4. DEFERRED COMMISSION

 

The Company paid commission to its salesmen based on cash collected from the sales. The Company calculated and paid commission based on certain proportion of monthly cash receipts from sales; however, the customers sometimes delays taking delivery of the products after payment is made to the Company, which is recorded as unearned revenue. Accordingly, the Company only recognizes current commission cost as the related revenue is recognized. Commission expenses are recorded as selling expenses. As of June 30, 2019 and December 31, 2018, the Company had deferred commission of $324,045 and $338,509 respectively.

 

5. DEFERRED TRAVEL COST

 

As part of the Company’s sales incentive program, the Company occasionally provided free travel to its customers whose prepayment to purchase the Company’s products reached a certain amount. There are different travel incentives offered to its customers based on amount received from each customer. The Company recorded the to-be-provided free travel cost when cash is collected from customers as deferred travel cost with corresponding account of accrued travel cost, and recorded as net of sales once the prepayment from customers was recognized as revenue. As of June 30, 2019 and December 31, 2018, the Company had deferred travel cost of $210,664 and $220,200, respectively.

 

6. INVENTORY

 

Inventory consisted of the following at June 30, 2019 and December 31, 2018:

 

  

June 30, 2019

   December 31, 2018 
Finished goods – health supplements  $6,268   $13,396 

 

7. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following at June 30, 2019 and December 31, 2018:

 

   June 30, 2019   December 31, 2018 
Office furniture  $46,051   $228,996 
Building   -    1,510,312 
Vehicles   213,803    212,972 
Electronic equipment   14,113    14,058 
Total   273,967    1,966,338 
Less: Accumulated depreciation   (200,261)   (501,923)
Net  $73,706   $1,464,415 

 

Depreciation for the six months ended June 30, 2019 and 2018 was $53,626 and $86,000, respectively. Depreciation for the three months ended June 30, 2019 and 2018 was $13,265 and $42,952, respectively.

 

The Company sold property rights to a portion of a building for RMB 9,000,000 ($1,340,862) and incurred a loss of $33,166 in the first quarter of 2019 and leased it back for two years beginning March 31, 2019. (See Note 10)

 

 15 
 

 

8. TAXES PAYABLE

 

Taxes payable consisted of the following at June 30, 2019 and December 31, 2018 (audited):

 

   June 30, 2019   December 31, 2018 
Income  $35,655   $35,517 
Value-added   1091,223    1,101,372 
City construction   47,660    48,541 
Education   34,000    34,683 
Other   9,848    2,373 
Taxes payable  $1,218,387   $1,222,486 

 

9. ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables consisted of the following at June 30, 2019 and December 31, 2018 (audited):

 

  

Jun 30, 2019

   December 31, 2018 
Accrued liability – travel cost (see Note 4)  $6,180    6,156 
Salary payable   193,283    162,030 
Other payables   577,067    527,189 
Total  $776,530   $695,375 

 

Other payables mainly consisted of payables for employees’ social insurance and disabled employment security fund of $337,585 and commission payable of $104,273 at June 30, 2019; and payables of employees’ social insurance and disabled employment security fund of $296,173 and commission payable of $103,978 at December 31, 2018, respectively.

 

10. LEASE

 

On September 12, 2018, the Company entered into a contract to sell its rights to a portion of a building (see Note 7), at which time the Buyer paid RMB 100,000 ($14,898) to a shareholder of the Company as a down payment. The contract stipulated the remaining RMB 8,900,000 ($1,325,964) should be paid by the Buyer on or before September 30, 2018 and before the Company would be required to go to the relevant authority to effectuate the transfer of its property rights. The Buyer failed to make the payment on or prior to September 30, 2018, a default under the contract which gave the Company the right to terminate the contract. In October 2018, the Buyer delivered to the shareholder an additional RMB 7 million ($1.0 million). On March 25, 2019, the parties entered in to a supplemental agreement which provided that the Company would transfer the property rights to Buyer if it agreed the Company would get the benefit of the RMB 7,000,000 ($1,042,893) and otherwise pay the remaining balance of RMB 1,200,000 ($178,782) on or prior to March 31, 2019. The RMB1,200,000 ($178,782) was paid directly to the shareholder on a timely basis and the Company was given the benefit of the RMB 8,900,000 ($1,325,964) delivered to the Shareholder.

 

As a result, $207,049 (RMB 1,389,731) was recorded as right of use assets and lease liability on March 31, 2019 when the lease commenced based on a 4.75% discount factor. The net right of use asset was $176,029 as of June 30, 2019, net of accumulated amortization of $26,669.

 

Maturities of lease liabilities were as follows:

 

For the 12 months ending June 30,:    
2020  $105,422 
2021   79,067 
Total lease payments   184,489 
Less imputed interest   (8,460)
Total   176,029 
Less Current Portion   (98,803)
Long Term Portion  $77,226 

 

 16 
 

 

The cost and accumulated depreciation of the building was $1,739,228 and $364,834, respectively. The Company recorded a loss on sale of $33,136 during the quarter ended March 31, 2019. $1,340,862 of the sale proceeds were collected by the principal shareholder which was offset against amounts due to the shareholder.

 

11. RELATED PARTY TRANSACTIONS

 

Advance from a Shareholder

 

At June 30, 2019 and December 31, 2018 (audited), the Company had advance to a major shareholder of $118,218 and $-0-, respectively. As of June 30, 2019 and December 31, 2018, the Company had an advance from the same major shareholder of $-0- and $1,166,198, respectively. The advance from the shareholder was payable on demand, and bore no interest and was satisfied though the sale of the building described in Note 10 with the excess of the amount paid to the shareholder by the Buyer recognized as an advance to shareholder.

 

Office lease from a Major Shareholder

 

In May 2014, the Company entered an office lease with its major shareholder; the lease term was three years until May 2017 with an option to renew. The monthly rent was RMB 5,000 ($721), the Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease in May 2017 for another three years until May 28, 2020 with monthly rents of RMB 5,000 ($721), payable quarterly. The future annual minimum lease payment at June 30, 2019 is $7,931 for the year ending June 30, 2020.

 

12. INCOME TAXES

 

The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, the PRC. The Company generated substantially all of its sales from its operations in the PRC for the six months ended June 30, 2019 and 2018, and recorded income tax provision for the periods.

 

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

 

Uncertain Tax Positions

 

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the six months ended June 30, 2019 and 2018, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

 

 17 
 

 

13. SHAREHOLDERS’ DEFICIT

 

The Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 950,000,000 shares of common stock at $.00001 par value per share. At June 30, 2019 and December 31, 2018, the Company had 287,838,699 shares issued and outstanding

 

14. STATUTORY RESERVES

 

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

 

Surplus reserve fund

 

The Company is now required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital.

 

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

 

Common welfare fund

 

Common welfare fund is a voluntary fund that the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations, to this fund. The Company did not make any contribution to this fund during the six months ended June 30, 2019 and 2018.

 

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

 

15. OPERATING CONTINGENCIES

 

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with company in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to effect the remittance.

 

The Company is, from time to time, involved in litigation incidental to the conduct of its business litigation regarding merchandise sold, including product litigation with respect to various employment matters, including litigation with present and former employees, wage and hour litigation and litigation regarding intellectual property rights.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

16. SUBSEQUENT EVENT

 

On August 7, 2019, AiXin Life International, Inc. (the “Company”) completed the sale of 10,000,000 shares of its common stock for gross proceeds of $1,000,000 in a private offering exempt from the registration requirements of the Securities Act pursuant to Regulation S. The sales were effected in off-shore transactions and none of the purchasers were U.S. Persons (as defined in Rule 902(k) of Regulation S). The Company did not pay any commissions in connection with the sale of the shares. The certificates representing the shares were imprinted with a legend restricting transfers and prohibiting hedging transactions in accordance with Regulation S.

 

 18 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes to those statements included elsewhere in this Form 10-Q and with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in our 2018 Form 10-K, that could cause actual results to differ materially from those anticipated in these forward-looking statements.

 

Overview

 

We, through our indirectly wholly owned subsidiary AiXin Zhonghong, market and sell consumer products in China by offering premium-quality nutritional products. We sell the products through our sales offices, exhibition events we organize and sponsor, and person-to-person marketing. Our revenue is primarily generated from the sales of our cell food, goat milk powder, clear lung Kangbao, light tea, bear gall powders, and other nutritional supplements. Our business mainly focuses on proactively approaching our customers such as by hosting events for clients, which we believe is ideally suited to marketing our products because sales of nutritional products are strengthened by ongoing personal contact and support, coaching and education among the Company and our clients towards how to achieve a healthy and active lifestyle.

 

We do not independently test products to determine efficacy. Rather we rely upon information we uncover through inquiries in the community and a review of scientific and other literature. Once we determine to offer a product and believe it will be purchased by our clients, we will purchase a bulk quantity, enabling us to acquire products at prices below those available to smaller distributors.

 

In addition to our ongoing operations, we seek to acquire an interest in additional businesses through opportunities found by our management or presented by persons or firms which desire to take advantage of the perceived advantages of an Exchange Act registered corporation. We do not restrict our search to any specific business, industry, or geographical location and may participate in a business venture of virtually any kind or nature. We are not currently engaged in negotiations regarding the acquisition of any business.

 

The chart below presents our current corporate structure:

 

AiXin Life International, Inc. (a Colorado corporation)
(formerly known as Mercari Communications Group, Ltd.)
           
100%
           
AiXin (BVI) International Group Co., Ltd (BVI)
           
100%
           

HK AiXin International Group Co., Limited (HK)

(“AiXin HK”)

           
100%
           

Chengdu Aixin Zhonghong Biological Technology Co., Ltd (PRC)

(“AiXin Zhonghong”)

 

Our executive offices are located at Hongxing International Business Building 2, 14thFL, No. 69 Qingyun South Ave., Jinjiang District, Chengdu City, Sichuan Province, China, and our telephone number is +86-28-8669-1072.

 

 19 
 

 

Results of Operations

 

The following table sets forth the results of our operations for the periods indicated as a percentage of net revenue, certain columns may not add due to rounding:

 

   Three Months Ended June 30, 
   2019   2018 
   $   % of Revenue    $    % of Revenue 
Revenue  $10,787    100%  $40,613    100%
Cost of revenue   4,234    39%   24,216    60%
Gross profit   6,553    61%   16,397    40%
Operating expenses   369,998    3430%   375,573    925%
Loss from operations   (363,445)   (3369)%   (359,176)   (885)%
Non-operating income (expenses), net   (806)   (8)%   (344)   (0.8)%
Income tax expense   -    -%   -    -%
Net loss  $(364,251)   (3377)%  $(359,520)   (886)%

 

   Six Months Ended June 30, 
   2019   2018 
   $   % of Revenue   $   % of Revenue 
Revenue  $101,266    100%  $145,161    100%
Cost of revenue   21,430    21%   64,574    44%
Gross profit   79,836    79%   80,587    56%
Operating expenses   721,356    712%   857,306    591%
Loss from operations   (641,520)   (633)%   (776,719)   (535)%
Non-operating income (expenses), net   (34,081)   (34)%   (750)   (1)%
Income tax expense   -    -%   -    -%
Net loss  $(675,601)   (667)%  $(777,469)   (536)%

 

Revenue

 

Revenue for the quarter ended June 30, 2019, was $10,787, while revenue for 2018 period was $40,613, a decrease of $29,826 or 73%. Revenue for the six months ended June 30, 2019, was $101,266, while revenue for the 2018 period was $145,161, a decrease of $43,895 or 30%. The decrease in sales was primarily because the market for health supplements declined as a result of the government’s exposure of fraudulent practices in the industry, reducing the demand for nutritional supplements. In addition, during this period of reduced demand, a substantial focus of our company was on adjusting our product structure, sales model, customer structure and infrastructure in order to build a solid foundation for future business development.

 

Cost of Revenue

 

Cost of revenue (“COR”) was $4,234 and $21,430 in the quarter and six months ended June 30, 2019, compared to $24,216 and $64,574 in the comparable 2018 periods, a decrease of $19,982 or 83% and $43,144 or 67%, respectively. The decrease in our COR is attributable to the decrease in our revenue. The COR as a percentage of sales was 39% and 21% in the quarter and six months ended June 30, 2019, compared to 60% and 44% for the comparable 2018 periods. The COR as a percentage of sales decreased because the Company has stopped selling certain higher cost products.

 

Gross Profit

 

Gross profit was $6,553 and $79,836 in the quarter and six months ended June 30, 2019, compared to $16,397 and $80,587 in the comparable 2018 periods, a decrease of $9,844 or 60% and $751 or 1%, respectively. The decrease in our gross profit was mainly due to the decrease of revenue. Gross margin was 61% and 79% in the quarter and six months ended June 30, 2019, compared to 40% and 56% for the comparable 2018 periods as a result of the decrease in the COR as a percentage of sales.

 

 20 
 

 

Operating Expenses

 

Operating expenses were $369,998 and $721,356 for the quarter and six months ended June 30, 2019, compared to $375,573 and $857,306 for the comparable 2018 periods, a decrease of $5,575 or 2% and $135,950 or 13%. The decrease in operating expenses in the first half of 2019 was mainly due to a $18,686 decrease in selling expense and a $124,380 decrease in general and administrative expenses as a result of a decrease in public company related expenses

 

Net Loss

 

Our net loss for the quarter and six months ended June 30, 2019, was $364,251 and $675,601compared to $359,520 and $777,469 for the comparable 2018 periods, an increase in net loss of $4,731 or 1% for the quarter and a decrease in net loss of $101,868 or 13% for the half. The increase in net loss in the quarter was mainly due to the lower gross profit, partially offset by lower operating expenses. The decrease in net loss in the first half of 2019 was mainly due to lower operating expenses, partially offset by the loss from disposal of fixed assets.

 

Liquidity and Capital Resources

 

Currently, we depend upon advances from our major shareholder to continue our operations. As of June 30, 2019, cash and equivalents were $3,465, compared to $11,264 as of December 31, 2018. At June 30, 2019, we had a working capital deficit of $(2,801,550) compared to the $(4,655,299) deficit at December 31, 2018. The decrease in the working capital deficit was mainly due to the building sale in the first quarter of 2019, partly offset by continued losses.

 

The following is a summary of cash provided by or used in each of the indicated types of activities during the six months ended June 30, 2019 and 2018, respectively.

 

  

June 30, 2019

  

June 30, 2018

 
Net cash used in operating activities  $(1,259,903)  $(450,830)
Net cash used in investing activities  $-   $(1,405)
Net cash provided by financing activities  $1,245,381   $414,340 

 

Net cash used in operating activities

 

For the six months ended June 30, 2019, net cash used in operating activities was $1,259,903. This was primarily due to a net loss of $675,601, adjusted by non-cash related expenses including depreciation of $80,295, provision for bad debt of $14,967, impairment of inventory of $1,063 and loss from sale of a building of $33,166, then decreased by unfavorable changes in working capital of $713,794. The unfavorable changes in working capital mainly resulted from an increase in advances to suppliers of $687,533, a decrease in unearned revenue of $89,354, and an increase in accounts receivable of $26,833, partly offset by an increase in accrued liabilities and other payables of $79,418.

 

For the six months ended June 30, 2018, net cash used in operating activities was $450,830. This was primarily due to a net loss of $777,469, adjusted by non-cash related expenses including depreciation of $86,000, provision for bad debt of $8,914 and recovery of inventory of $15,356, then increased by favorable changes in working capital of $247,081. The favorable changes in working capital mainly resulted from an increase in accrued liabilities and other payables of $196,650, an increase in accounts payable of $17,097, a decrease in inventory of $48,403, a decrease in deferred commission of $18,092, and a decrease in deferred travel cost of $15,867, partly offset by a decrease in unearned revenue of $67,256.

 

 21 
 

 

Net cash used in investing activities

 

For the six months ended June 30, 2018, net cash used in investing activities was $1,405 for purchase of property and equipment.

 

Net cash provided by financing activities

 

For the six months ended June 30, 2019, net cash provided by financing activities was $1,245,381 which was mainly due to shareholder capital contributions of $1,249,125, partly offset by lease liability payment of $8,890.

 

For the six months ended June 30, 2018, net cash provided by financing activities was $414,340 which was due to shareholder capital contributions of $142,912 and an advance from shareholder of $271,428.

 

Recent Private Placement

 

To supplement our cash on August 7, 2019, we completed the sale of 10,000,000 shares of our common stock for gross proceeds of $1,000,000 in a private offering exempt from the registration requirements of the Securities Act pursuant to Regulation S. The sales were effected in off-shore transactions and none of the purchasers were U.S. Persons (as defined in Rule 902(k) of Regulation S). We did not pay any commissions in connection with the sale of the shares.

 

Impact of Inflation

 

The general annual inflation rate in China was 2.5% in 2018 and 1.4% in 2017 according to the National Bureau of Statistics. Our results of operations may be affected by inflation, particularly rising prices for products and other operating costs.

 

Contractual Obligations

 

We have no long-term fixed contractual obligations or commitments.

 

Off-Balance Sheet Arrangements

 

We have not entered into any financial guarantees or other commitments to guarantee the obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any uncombined entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

Contingencies

 

The Company’s operations are conducted in the PRC and are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments in China and foreign currency exchange. The Company’s results may be adversely affected by changes in PRC government policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expense transactions in China are denominated in RMB and all of the Company’s assets and liabilities in China are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current PRC law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation in order to affect the remittance.

 

 22 
 

 

Significant Accounting Policies

 

While our significant accounting policies are more fully described in Note 2 to our financial statements, we believe the following accounting policies are the most critical to aid you in fully understanding and evaluating this management discussion and analysis.

 

Basis of Presentation

 

The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of Aixin is Chinese Renminbi (‘‘RMB’’). The accompanying financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

Going Concern

 

We incurred net losses of $675,601 and $777,469 for the six months ended June 30, 2019 and 2018, respectively. We also had a stockholders’ deficit of $2.6 million as of June 30, 2019. These conditions raise a substantial doubt about our ability to continue as a going concern. We plan to increase our income by improving communications with suppliers to ensure a sufficient supply of quality products, building a competitive and efficient sales force, providing an attractive sales incentive program, increasing marketing and promotional activities, and minimizing operating costs. Subsequent to the close of the second quarter, we sold 10,000,000 shares of our common stock for gross proceeds of $1,000,000 in a private offering. We did not pay any commissions in connection with the sale of the shares. If necessary, we will seek to raise additional capital through sales of our equity securities to solve our working capital needs. As of June 30, 2019, we had received RMB 15.6 million (approximately $2.2 million) from Quanzhong Lin, our majority shareholder. Our financial statements included herein do not include any adjustments that might result from the outcome of this uncertainty.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Accounts Receivable

 

The Company maintains an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. During the six months ended June 30, 2019 and 2018, bad debt expense was $14,967 and $8,914, respectively. As of June 30, 2019 and December 31, 2018, the bad debt allowance was $93,049 and $32,667, respectively.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As sales are and have been primarily from platform fees and related services, and the Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on our accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

 23 
 

 

Revenue from sale of goods under Topic 606 in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with our customers that we believe is legally enforceable;

 

  identification of performance obligation in the respective contract;

 

  determination of the transaction price for each performance obligation in the respective contract;

 

  allocation the transaction price to each performance obligation; and

 

  recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements, as applied to each of the Company’s revenue category, is summarized below:

 

 

Revenue from sale of goods is recognized when goods are shipped to the customer and no other obligation exits. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As alternatives for the product return option, the customers have options of asking an exchange of the products with same value.

 

As part of the Company’s sales incentive program, the Company occasionally provides free travel to its customers whose prepayment to purchase the Company’s products reaches to certain amount. There are different travel incentives offered to the customers based on amount received from each customer. The Company records the to-be-provided free travel cost when cash is collected from customers as a debit deferred travel cost with corresponding credit to accrued travel cost. Once the customer utilizes the travel incentive, the cost of travel is recorded as a reduction of sales.

 

Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price prior to May 1, 2018, 16% since May 1, 2018 and 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive income (loss) is comprised of net income (loss) and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for the first half of 2019 and 2018 consisted of net loss and foreign currency translation adjustments.

 

 24 
 

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early application is permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its CFS.

 

 25 
 

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Management of AiXin Life International, Inc. is responsible for maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. In addition, the disclosure controls and procedures must ensure that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

 

At June 30, 2019, an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”)) was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based on their evaluation of our disclosure controls and procedures, they concluded that at June 30, 2019, such disclosure controls and procedures were not effective. This was due to our limited resources, including the absence of a financial staff with accounting and financial expertise and deficiencies in the design or operation of our internal control over financial reporting that adversely affected our disclosure controls and that may be considered to be “material weaknesses.” These deficiencies resulted in the failure to include in the financial statements for the first quarter of 2019 the sale of property rights to a portion of a building and the lease liability arising from the lease back of the building, the satisfaction of an advance due to a shareholder and the making of an advance to a related party.

 

We plan to designate individuals responsible for identifying reportable developments and to implement procedures designed to remediate the material weakness by focusing additional attention and resources in our internal accounting functions. However, the material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 26 
 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There is no pending litigation to which the Company is presently a party or to which the Company’s property is subject and management is not aware of any litigation which may arise in the future.

 

Item 1A. Risk Factors

 

Reference is made to the risks and uncertainties disclosed in Item 1A (“Risk Factors”) of our 2018 Form 10-K, which are incorporated by reference into this report. Prospective investors are encouraged to consider the risks described in the 2018 Form 10-K, Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and other information publicly disclosed or contained in documents we file with the Securities and Exchange Commission before purchasing our securities. In particular, we note that approximately 95% of our outstanding shares of common stock are owned by members of our management and that there is no regular trading market for our common stock. Consequently, the trading price of our common stock is subject to wide fluctuations and, as is likely the case in respect of recent reported prices, may exceed the value of our company based upon the value of its assets or generally recognized valuation measures.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the quarter ended June 30, 2019, we did not have any sales of equity securities in transactions that were not registered under the Securities Act of 1933, as amended, that have not been previously reported in a report filed pursuant to the Exchange Act.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit

No.

  Description
     
2.1   Share Exchange Agreement, dated as of December 12, 2017, among the Company, AiXin BVI, AiXin HK, AiXinZhonghong and the stockholders of AixinZhonghong (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 14, 2017).
     
3.1   Articles of Incorporation (incorporated by reference to the Company’s Annual Report on Form 10-KSB for the fiscal year ended May 31, 2006 as filed with the SEC on March 7, 2007).
     
3.2   Articles of Amendment to Articles of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 3, 2008).
     
3.3   Articles of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.3 the Company’s Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2017 as filed with the SEC on January 16, 2019).
     
3.4   Bylaws of the Registrant (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 3, 2008).
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14 or Rule 15d-14 of Securities Exchange Act of 1934.
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14 or Rule 15d-14 of Securities Exchange Act of 1934.
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema
101.CAL   XBRL Taxonomy Extension Calculation
101.DEF   XBRL Taxonomy Extension Definition
101.LAB   XBRL Taxonomy Extension Label
101.PRE   XBRL Taxonomy Extension Presentation

 

 27 
 

 

SIGNATURES

 

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AIXIN LIFE INTERNATIONAL, INC.
     
Dated: September 26, 2019 By: /s/ Quanzhong Lin
    Quanzhong Lin
    President and Chief Executive Officer
    (Principal Executive Officer)

 

 28